Comparative Analysis of Elevated Serum Total and Free Triiodothyronine Results Obtained by Immunoassays
Thyroid® · 01.07.2026 · 36 (7) · 795-799
DOI: 10.1177/10507256261450106 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Thyroid®, online erschienen am 09.05.2026. Verfasst von Roger Frigério Castilho und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medical Sciences, University of Campinas, Campinas, Brazil. Hauptthemen laut MEDLINE: Triiodothyronine, Thyrotoxicosis. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Background
Measurement of triiodothyronine (T3) levels is important for the laboratory diagnosis and management of certain cases of thyrotoxicosis and for identifying conditions involving altered peripheral conversion of thyroxine (T4) to T3. However, whether total T3 (TT3) or free T3 (FT3) should be measured remains unclear.
Methods
In this study, we performed a retrospective analysis of the results from 605 blood samples from 465 patients, in which thyroid-stimulating hormone (TSH), free T4 (FT4), TT3, and FT3 levels were measured in parallel. All the parameters were quantified using a widely used, fully automated electrochemiluminescence immunoassay platform, and reference intervals were based on those provided by the diagnostic test manufacturer.
Results
Despite a strong correlation between the TT3 and FT3 values (T3T ≤ 200 ng/dL: b = 0.0020, 95% confidence interval [CI]: 0.0019–0.0021, r = 0.841; T3T > 200 ng/dL: b = 0.0054, 95% CI: 0.0044–0.0064, r = 0.855), among 41 patients with elevated T3 values, 13 showed elevation of either TT3 or FT3, with a mild discordance between these values. Analysis of these discordant cases revealed a predominant pattern in which the FT3 levels better reflect clinical features and TSH and FT4 results than TT3 levels.
Conclusions
The TT3 and FT3 results were generally well correlated, with elevated FT3 demonstrating performance superior to that of elevated TT3. Future studies should validate these findings across diverse populations with specific reference intervals and multiple immunoassay platforms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Medical Sciences, University of Campinas, Campinas, Brazil.
- Clinical Physiology Laboratory, Clinical Pathology Division, University Hospital, University of Campinas, Campinas, Brazil.
- Department of Obstetrics and Gynecology, School of Medical Sciences, University of Campinas, Campinas, Brazil.
- Department of Internal Medicine, Endocrinology Division, School of Medical Sciences, University of Campinas, Campinas, Brazil.
ORCID-Profile: Roger Frigério Castilho
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Castilho, R. F., de Almeida, R. A., Lintz, C. H. C. P., Ribeiro-do-Valle, C. C., & Zantut-Wittmann, D. E. (2026). Comparative Analysis of Elevated Serum Total and Free Triiodothyronine Results Obtained by Immunoassays. Thyroid®, 36(7), 795-799. https://doi.org/10.1177/10507256261450106
Vancouver
Castilho RF, de Almeida RA, Lintz CHCP, Ribeiro-do-Valle CC, Zantut-Wittmann DE. Comparative Analysis of Elevated Serum Total and Free Triiodothyronine Results Obtained by Immunoassays. Thyroid®. 2026;36(7):795-799. doi:10.1177/10507256261450106
BibTeX
@article{Castilho2026,
author = {Castilho, Roger Frigério and de Almeida, Rafael Almeida and Lintz, Cintia Heloisa Correa Pilenso and Ribeiro-do-Valle, Carolina Carvalho and Zantut-Wittmann, Denise Engelbrecht},
title = {Comparative Analysis of Elevated Serum Total and Free Triiodothyronine Results Obtained by Immunoassays},
journal = {Thyroid®},
year = {2026},
volume = {36},
number = {7},
pages = {795--799},
doi = {10.1177/10507256261450106}
}
EUVIMED